glp 1 drugs muscle loss Some people taking GLP-1 weight are concerned about loss. In general, people with obesity have more muscle mass than people without obesity — simply because their bodies have to Unlocking the Truth: Muscle Mass
Description
The Misinformation Machine: Big Pharmas Narrative Strategy In early 2025, the FDA announced that shortages of semaglutide and tirzepatide had been resolved

doi: 10.1038/ijo.2011.158

The impact will also be felt more broadly within the healthcare sector

doi: 10.1097/JGP.0b013e31822001c1 22 CabouC.BurcelinR

The medullary thyroid carcinoma warning All GLP-1 receptor agonists carry a black-box warning, the most serious warning the FDA issues, regarding thyroid C-cell tumors
S.MartoranaF.et al (2019)
